The targeting construct replaced exon 2 with a tTA and a floxed neomycin resistance cassette driven by a tetracycline response element and CMV promoter. A third loxP site was inserted between exon 2 and 3. Cre-mediated recombination removed the selection cassette. (J:321349)
Basic Information
(129X1/SvJ x 129S1/Sv)F1-Kitl+
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count